Obinutuzumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Obinutuzumab and local guidelines before prescribing.

Anti-CD20 antibody

Mechanism

Anti-CD20 monoclonal antibody.

Uses

CLL, follicular lymphoma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infusion reactions, tumour lysis syndrome, neutropenia, PML.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active infection

Monitoring

FBC, U&E

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Tumour lysis prophylaxis; hepatitis B screen.

More from the textbook: uses, cautions and other points
Where it is discussed in the book